Browse by Medical Category
Accepting New Patients
Mary Sabatini, MD, specializes in reproductive endocrinology and fertility preservation for cancer patients. She is the medical director of the Clinic for Reproductive Health and Cancer.
Obstetrics & Gynecology
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Mary Sabatini, MD, PhD, is the Medical Director of the Oncofertility Clinic and the Medical Director of the Third-Party Reproduction Program in the Reproductive Endocrinology and Infertility Division of the Department of Obstetrics and Gynecology at Massachusetts General Hospital. She is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School.
Her primary research interests include exploring novel approaches to fertility preservation in those diagnosed with cancer and understanding clinical outcomes for women with hereditary cancer syndromes.
View my most recent publications at PubMed
Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, Sabatini ME, Gao G, Donahoe PK, Pépin D. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proceedings of the National Academy of Sciences USA. 2017 Feb 28;114(9):E1688-E1697.
Mínguez-Alarcón L, Chiu YH, Messerlian C, Williams PL, Sabatini ME, Toth TL, Ford JB, Calafat AM, Hauser R; EARTH Study Team. Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic. Fertility & Sterility. 2016 Mar;105(3):714-21.
Hariton E, Bortoletto P, Cardozo ER, Hochberg EP, Sabatini ME. The Role of Oncofertility Clinics in Facilitating Access to Reproductive Specialists. Accepted and awaiting publication in Journal of Patient Experience
Cardozo E, Karmon A, Longacre MM and Sabatini ME. The Role of Demographics and Diagnosis on Fertility Preservation Decision Making Among Female Cancer Patients of Reproductive Age. Accepted and awaiting publication in Journal of Reproductive Medicine
Hariton E, Kim K, Mumford SL, Palmor M, Bortoletto P, Cardozo ER, Karmon A, Sabatini ME, Styer AK. Total number of Oocytes and Zygotes are Predictive of Live Birth Pregnancy in Fresh Donor Oocyte IVF CyclesAccepted for publication 2017 – Fertility & Sterility
"Fertility and Cancer: Fertility Preservation and Fertility Sparing Surgery" (Chapter 15) in Translational Advances in Gynecologic Cancers (1st Edition, 2017)Editors: Michael Birrer & Lorenzo Ceppi
See more publications on PubMed.
New oncofertility research at Mass General offers a promising new paradigm for a reversible contraceptive that may help protect the ovaries during chemotherapy.
Back to Top